Extendicare Inc.
TSX:EXE.TOMedical - Care Facilities
+$0.86 today
- Market cap
- $2.74B
- Beta
- 1.16
- P/E (TTM)
- 26.4
- EPS (TTM)
- $1.28
- Dividend yield
- 1.51%
Volume 0.86M
Average 0.34M
EXE.TO Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Extendicare Inc.TSX: EXE.TO
Common Stock · Q2 FY2026 · quarter ended Jun 2026
Common stock rises 41.3% from a year ago
Common stock stood at CA$663.3M at the end of Q2 FY2026, up 41.3% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +11.7% a year.
Context
- Common stock amounted to 42.6% of total assets at the end of Q2 FY2026, down 17.7 pp from a year earlier.
- Common stock increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +41.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
CAD · from the balance sheet
- Latest · FY2025
- 662.85M CAD
- Year-over-year change
- +41.2%
- 4-year CAGR
- +7.3%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 662.85M | +41.2% |
| FY2024 | 2024-12-31 | 469.33M | +0.4% |
| FY2023 | 2023-12-31 | 467.35M | -1.7% |
| FY2022 | 2022-12-31 | 475.42M | -5.1% |
| FY2021 | 2021-12-31 | 500.88M | — |
Common Stock vs competitors
How EXE.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +41.3% is the highest of 7, against a peer median of +0.8%.
- Common stock amounts to 42.6% of total assets for EXE.TO, versus a peer median of 57.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | CA$1.65B CAD | +29.0% | +12.9% | 59.5% | |
| Mar 2026 | CA$814.76M CAD | +1.5% | +4.6% | 37.6% | |
| Jun 2026 | CA$663.3M CAD | +41.3% | +11.7% | 42.6% | |
| Mar 2026 | $647.5M USD | -3.2% | +2.7% | 55.2% | |
| Mar 2026 | CA$332.96M CAD | +0.1% | +3.5% | 133.8% | |
| Mar 2026 | $251.86M USD | -7.7% | -10.5% | 90.6% | |
| Feb 2026 | $116K USD | +17.2% | +26.0% | 0.0% | |
| Peer median (excluding EXE.TO) | — | +0.8% | +4.1% | 57.3% | |
Competitors are the stored peer set for EXE.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 104.63M | 167.28M | 75.18M | 121.85M | 349.18M |
| Short-term Investments | 0 | 0 | 729K | 0 | 0 |
| Net Receivables | 83.54M | 64.07M | 91.03M | 92.32M | 85.18M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 36.76M | 26.68M | 20.2M | 29.53M | 17.58M |
| Total Current Assets | 224.92M | 258.04M | 187.14M | 243.7M | 451.93M |
| Property, Plant & Equipment (Net) | 535.6M | 388.72M | 295.9M | 295.23M | 353.69M |
| Goodwill | 45.85M | 45.85M | 45.85M | 45.85M | 92.23M |
| Intangible Assets | 46.63M | 51.21M | 78.46M | 75.06M | 103.07M |
| Long-term Investments | 0 | 0 | 24.53M | 24.75M | 24.47M |
| Tax Assets | 14.43M | 7.29M | 5.89M | 5.77M | 7.67M |
| Other Non-current Assets | 32.89M | 30.47M | 34.98M | 29.43M | 33.45M |
| Total Non-current Assets | 675.4M | 523.54M | 485.59M | 476.09M | 614.58M |
| Total Assets | 900.32M | 781.58M | 672.73M | 719.79M | 1.07B |
| Account Payables | 192.99M | 250.14M | 197.09M | 241.5M | 298.74M |
| Short-term Debt | 73.58M | 19.24M | 19.88M | 31.09M | 19.85M |
| Tax Payables | 1.57M | 5.61M | 3.25M | 20.29M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 13.78M | 0 | 6.17M | 0 | 0 |
| Total Current Liabilities | 281.91M | 274.99M | 226.39M | 292.88M | 330.18M |
| Long-term Debt | 408.94M | 364.74M | 277.72M | 249.74M | 310.36M |
| Deferred Tax Liabilities | 8.8M | 6.89M | 10.09M | 7.16M | 11.43M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 44.42M | 34.27M | 33.69M | 34M | 28.46M |
| Total Non-current Liabilities | 516.49M | 405.89M | 358.43M | 302.55M | 362.97M |
| Total Liabilities | 798.4M | 680.88M | 584.81M | 595.44M | 693.15M |
| Common Stock | 500.88M | 475.42M | 467.35M | 469.33M | 662.85M |
| Retained Earnings | (402.45M) | (384.62M) | (393.47M) | (352.55M) | (299.68M) |
| Accumulated OCI | (4.68M) | (713K) | 957K | (6.76M) | (6.09M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 101.92M | 100.7M | 87.92M | 124.35M | 373.37M |
| Total Debt | 536.85M | 383.97M | 334.52M | 292.49M | 342.93M |
| Net Debt | 432.22M | 216.69M | 259.33M | 170.64M | (6.25M) |
Extendicare Inc.
TSX:EXE.TO
Intrinsic Alpha fair value
Locked
Current Price
$28.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.